Company
Azora Therapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Azora Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule new chemical entities for the treatment of autoimmune, inflammatory diseases. Our team has decades of experience in drug development and has helped develop groundbreaking medicines for patients, including Uceris®, Tysabri®, Ycanth® and Humira®.
Loading relationship preview